Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Cetirizine Hydrochloride Injection in the Treatment of Acute Urticaria: a Randomized, Double-blind, Positive Controlled, Multicenter Phase III Clinical Study

NCT06819774 is registered in ClinicalTrials.gov with Shandong New Time Pharmaceutical Co., LTD as lead sponsor.

NCT NCT06819774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06819774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Cetirizine Hydrochloride Injection in the Treatment of Acute Urticaria: a Randomized, Double-blind, Positive Controlled, Multicenter Phase III Clinical Study
Lead sponsor
Shandong New Time Pharmaceutical Co., LTD
Phase
Phase 3
Overall status
Recruiting
Start date
April 22, 2024
Completion date
August 31, 2025
Enrollment
284 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute urticaria